Literature DB >> 10913176

Repression of RNA polymerase I transcription by the tumor suppressor p53.

W Zhai1, L Comai.   

Abstract

The tumor suppressor protein p53 is frequently inactivated in tumors. It functions as a transcriptional activator as well as a repressor for a number of viral and cellular promoters transcribed by RNA polymerase II (Pol II) and by RNA Pol III. Moreover, it appears that p53 also suppresses RNA Pol I transcription. In this study, we examined the molecular mechanism of Pol I transcriptional inhibition by p53. We show that wild-type, but not mutant, p53 can repress Pol I transcription from a human rRNA gene promoter in cotransfection assays. Furthermore, we show that recombinant p53 inhibits rRNA transcription in a cell-free transcription system. In agreement with these results, p53-null epithelial cells display an increased Pol I transcriptional activity compared to that of epithelial cells that express p53. However, both cell lines display comparable Pol I factor protein levels. Our biochemical analysis shows that p53 prevents the interaction between SL1 and UBF. Protein-protein interaction assays indicate that p53 binds to SL1, and this interaction is mostly mediated by direct contacts with TATA-binding protein and TAF(I)110. Moreover, template commitment assays show that while the formation of a UBF-SL1 complex can partially relieve the inhibition of transcription, only the assembly of a UBF-SL1-Pol I initiation complex on the rDNA promoter confers substantial protection against p53 inhibition. In summary, our results suggest that p53 represses RNA Pol I transcription by directly interfering with the assembly of a productive transcriptional machinery on the rRNA promoter.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10913176      PMCID: PMC86070          DOI: 10.1128/MCB.20.16.5930-5938.2000

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  52 in total

1.  Expression of cell cycle regulatory proteins (p53, pRb) in the human female genital tract.

Authors:  A Bukovsky; M R Caudle; J A Keenan; J Wimalasena; J S Foster; N B Upadhyaya; S E van Meter
Journal:  J Assist Reprod Genet       Date:  1995-02       Impact factor: 3.412

2.  Molecular mechanisms governing species-specific transcription of ribosomal RNA.

Authors:  S P Bell; C S Pikaard; R H Reeder; R Tjian
Journal:  Cell       Date:  1989-11-03       Impact factor: 41.582

3.  Functional cooperativity between transcription factors UBF1 and SL1 mediates human ribosomal RNA synthesis.

Authors:  S P Bell; R M Learned; H M Jantzen; R Tjian
Journal:  Science       Date:  1988-09-02       Impact factor: 47.728

Review 4.  Biochemical properties and biological effects of p53.

Authors:  R Haffner; M Oren
Journal:  Curr Opin Genet Dev       Date:  1995-02       Impact factor: 5.578

5.  In vitro transcription: whole-cell extract.

Authors:  J L Manley; A Fire; M Samuels; P A Sharp
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

6.  Eukaryotic gene transcription with purified components.

Authors:  J D Dignam; P L Martin; B S Shastry; R G Roeder
Journal:  Methods Enzymol       Date:  1983       Impact factor: 1.600

7.  Wild type human p53 is antiproliferative in SV40-transformed hamster cells.

Authors:  W E Mercer; M Amin; G J Sauve; E Appella; S J Ullrich; J W Romano
Journal:  Oncogene       Date:  1990-07       Impact factor: 9.867

8.  Nuclear and nucleolar targeting sequences of c-erb-A, c-myb, N-myc, p53, HSP70, and HIV tat proteins.

Authors:  C V Dang; W M Lee
Journal:  J Biol Chem       Date:  1989-10-25       Impact factor: 5.157

9.  Negative feedback regulation of wild-type p53 biosynthesis.

Authors:  J Mosner; T Mummenbrauer; C Bauer; G Sczakiel; F Grosse; W Deppert
Journal:  EMBO J       Date:  1995-09-15       Impact factor: 11.598

10.  A possible mechanism for the inhibition of ribosomal RNA gene transcription during mitosis.

Authors:  D Weisenberger; U Scheer
Journal:  J Cell Biol       Date:  1995-05       Impact factor: 10.539

View more
  120 in total

1.  p53 induction of heparin-binding EGF-like growth factor counteracts p53 growth suppression through activation of MAPK and PI3K/Akt signaling cascades.

Authors:  L Fang; G Li; G Liu; S W Lee; S A Aaronson
Journal:  EMBO J       Date:  2001-04-17       Impact factor: 11.598

2.  The tumor suppressor p53 inhibits Net, an effector of Ras/extracellular signal-regulated kinase signaling.

Authors:  Koji Nakade; Hong Zheng; Gitali Ganguli; Gilles Buchwalter; Christian Gross; Bohdan Wasylyk
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

3.  Transcriptional repression by p53 promotes a Bcl-2-insensitive and mitochondria-independent pathway of apoptosis.

Authors:  Nelly Godefroy; Sylvina Bouleau; Gaëtan Gruel; Flore Renaud; Vincent Rincheval; Bernard Mignotte; Diana Tronik-Le Roux; Jean-Luc Vayssière
Journal:  Nucleic Acids Res       Date:  2004-08-23       Impact factor: 16.971

4.  Putative involvement of the histone acetyltransferase Tip60 in ribosomal gene transcription.

Authors:  Kalipso Halkidou; Ian R Logan; Susan Cook; David E Neal; Craig N Robson
Journal:  Nucleic Acids Res       Date:  2004-03-11       Impact factor: 16.971

5.  Las1L is a nucleolar protein required for cell proliferation and ribosome biogenesis.

Authors:  Christopher D Castle; Erica K Cassimere; Jinho Lee; Catherine Denicourt
Journal:  Mol Cell Biol       Date:  2010-07-20       Impact factor: 4.272

6.  SILAC analysis of oxidative stress-mediated proteins in human pneumocytes: new role for treacle.

Authors:  Xunbao Duan; Steve G Kelsen; Allen B Clarkson; Rong Ji; Salim Merali
Journal:  Proteomics       Date:  2010-06       Impact factor: 3.984

Review 7.  p53, a translational regulator: contribution to its tumour-suppressor activity.

Authors:  V Marcel; F Catez; J-J Diaz
Journal:  Oncogene       Date:  2015-03-02       Impact factor: 9.867

8.  Global Inhibition with Specific Activation: How p53 and MYC Redistribute the Transcriptome in the DNA Double-Strand Break Response.

Authors:  Joshua R Porter; Brian E Fisher; Laura Baranello; Julia C Liu; Diane M Kambach; Zuqin Nie; Woo Seuk Koh; Ji Luo; Jayne M Stommel; David Levens; Eric Batchelor
Journal:  Mol Cell       Date:  2017-08-31       Impact factor: 17.970

9.  tp53-dependent and independent signaling underlies the pathogenesis and possible prevention of Acrofacial Dysostosis-Cincinnati type.

Authors:  Kristin E N Watt; Cynthia L Neben; Shawn Hall; Amy E Merrill; Paul A Trainor
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

10.  A targeting modality for destruction of RNA polymerase I that possesses anticancer activity.

Authors:  Karita Peltonen; Laureen Colis; Hester Liu; Rishi Trivedi; Michael S Moubarek; Henna M Moore; Baoyan Bai; Michelle A Rudek; Charles J Bieberich; Marikki Laiho
Journal:  Cancer Cell       Date:  2014-01-13       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.